Cite

HARVARD Citation

    Etienne-Selloum, N. et al. (n.d.). P14.122 Integrin α5 is a poor prognostic factor in patients with glioblastoma treated by the Stupp protocol. Neuro-oncology. p. iii97. [Online]. 
  
Back to record